Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Assets: 2021-2024

Historic Assets for Abivax (ABVX) over the last 4 years, with Dec 2024 value amounting to $219.3 million.

  • Abivax's Assets fell 55.80% to $135.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $135.4 million, marking a year-over-year decrease of 55.80%. This contributed to the annual value of $219.3 million for FY2024, which is 37.68% down from last year.
  • Per Abivax's latest filing, its Assets stood at $219.3 million for FY2024, which was down 37.68% from $351.9 million recorded in FY2023.
  • In the past 5 years, Abivax's Assets ranged from a high of $351.9 million in FY2023 and a low of $79.6 million during FY2022.
  • For the 3-year period, Abivax's Assets averaged around $216.9 million, with its median value being $219.3 million (2024).
  • Its Assets has fluctuated over the past 5 years, first crashed by 38.40% in 2022, then surged by 341.97% in 2023.
  • Yearly analysis of 4 years shows Abivax's Assets stood at $129.3 million in 2021, then tumbled by 38.40% to $79.6 million in 2022, then surged by 341.97% to $351.9 million in 2023, then slumped by 37.68% to $219.3 million in 2024.